The Food and Drug Administration (FDA) on Tuesday announced a new initiative titled “Operation Stork Speed” aimed at ...

The announcement comes as Kennedy has long touted the effectiveness of a healthy diet mitigating disease in humans.

Company expects to have sufficient cash to fund planned operations beyond the FDA PDUFA goal date and anticipated fourth ...

INmune Bio's high-upside potential with CORDStrom for RDEB and XPro for Alzheimer's, offering up to 144.8x returns. Click here to read why INMB is a Strong Buy.

The U.S. Health and Human Services Secretary is pushing to end a rule that allows food companies to use additives that ...

Investing.com -- The U.S. Food and Drug Administration (FDA) and the Department of Health and Human Services (HHS) unveiled a series of actions and programs on Tuesday, aimed at improving the quality, ...

The U.S. FDA and HHS announced on Tuesday a set of actions and initiatives focused on infant formula to ensure the ongoing quality, safety, nutritional adequacy and resilience of the domestic infant ...

HC Wainwright initiated coverage on Alpha Cognition, noting a new twist on a tried-and-tested treatment paradigm.

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for finerenone for the treatment of ...

Johnson & Johnson's nipocalimab receives FDA Fast Track status for Sjögren's disease, following strong Phase 2 trial results on disease activity and IgG reduction.

Despite the Trump administration's shake-up of the agency, the US FDA is the first port of call for most ASX biotechs.

One practice now under greater scrutiny is health care insurers’ use of artificial intelligence (AI) algorithms to deny ...